PEMF vs controls: less back pain in a 2026 review

Q: Did PEMF reduce back pain compared with usual care or sham?

A: A 2026 systematic review and network meta-analysis found lower chronic low-back-pain scores with PEMF than with usual care or sham stimulation: an average difference of 1.10 points on a 0–10 scale. The treatment schedules varied, and this average was smaller than the review’s 1.5-point threshold for a clinically meaningful change.

What the review compared

Yuntong Zhang, Wenchao Shen and colleagues compared nine physical therapies for adults with low-back pain lasting more than 12 weeks. Their review included 50 randomized trials and 2,811 people across all nine approaches—not 2,811 people treated with PEMF.

The analysis combined direct and indirect comparisons. PEMF was compared with usual care or sham stimulation, often alongside routine physiotherapy. The authors searched four research databases through November 2025 and published their analysis on August 23, 2026.

A modest reduction in pain

For PEMF, the average pain score was 1.10 points lower on a 0–10 scale than with usual care or sham. The 95% credible interval ranged from 0.41 to 1.79 points lower. Because that interval excludes zero, the review found a statistically significant pain benefit.

The size of that difference matters. The review used a 1.5-point reduction as its threshold for a clinically meaningful pain change. The average PEMF difference was below that threshold. It is a measured benefit, but not evidence that everyone will feel a large improvement.

Pain relief and everyday function were different

PEMF did not show a statistically significant improvement in disability compared with usual care. Disability was measured using the Oswestry Disability Index, which asks about the impact of back pain on everyday activities.

Other approaches ranked higher for pain reduction, including transcranial magnetic stimulation, peripheral magnetic stimulation and shock-wave therapy. A ranking is not a percentage of people who improved, and it does not remove uncertainty in the underlying trials.

Why there is no single treatment timetable

The review brought together different patient groups, treatment schedules and comparison groups. Across all nine approaches, treatment lasted from one session to 12 weeks. The PEMF trials also used different settings and courses; this was not a single shared protocol or follow-up visit.

The authors reported substantial differences among studies and limitations in trial quality. Some studies were small, and some comparisons relied partly on indirect evidence. The findings support further careful research on pulsed fields for chronic back pain, rather than a promise of lasting relief from a particular session.

ResultWhat the paper reported
Pain with PEMFMean difference versus usual care or sham: −1.10 points on a 0–10 scale; 95% credible interval −1.79 to −0.41.
Size of the average benefitThe 1.10-point pain difference was below the review’s 1.5-point threshold for a clinically meaningful change.
DisabilityPEMF did not show a statistically significant disability benefit versus usual care.
Whole review50 randomized trials; 2,811 participants across nine approaches. Pain analysis: 48 trials and 2,723 participants.

For a quiet session, explore Backache Chronic Lower or Backache in the KYMA library. These sets match the lower-back topic; the review studied clinical field treatments, not these saved programs or headphone listening.

Frequently asked questions

How much lower were pain scores with PEMF?

The estimated average was 1.10 points lower on a 0–10 scale than with usual care or sham. The 95% credible interval was 0.41 to 1.79 points lower. This was statistically significant, while the average remained below the review’s 1.5-point threshold for a clinically meaningful change.

Did everyday function improve as well?

PEMF did not show a statistically significant disability improvement versus usual care. Lower pain scores and better everyday function are separate outcomes.

Were all 2,811 people treated with PEMF?

That total covers all 50 trials and nine physical therapies. It is not the PEMF-only sample.

Which KYMA programs relate to the lower-back topic?

Open Backache Chronic Lower or Backache for a related library session. They are topic-matched programs, not the clinical protocols compared in this review; the review did not test these saved sets or headphone listening.

Original research

Read Comparative Efficacy of Physical Agent Therapies for Chronic Low Back Pain-A Systematic Review and Network Meta-Analysis, by Yuntong Zhang, Wenchao Shen, Xu Jiang, Xinyu Zhao, Siqing Huang, Roger Adams, Adrian Pranata, Zhengquan Chen, Chao Jiang and Jia Han. Published August 23, 2026 in the Journal of Pain Research. DOI: 10.2147/JPR.S629359; PMID: 42662494.

KYMA is working to establish a science-based podcast, because reliable information about this topic is almost impossible to find on ordinary social media.

Loading KYMA…